Upgrade to SI Premium - Free Trial

Wells Fargo Downgrades Amgen (AMGN) to Equal Weight

August 7, 2024 3:33 AM
Wells Fargo analyst Mohit Bansal downgraded Amgen (NASDAQ: AMGN) from Overweight to Equal Weight with a price target of $335.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Downgrades

Next Articles